Results

1–2 of 2 results for niu

Safety and Efficacy of Brepocitinib, a TYK2/JAK1 Inhibitor, in Active Non-Infectious Uveitis: 24-Week Results from a 52-Week Phase 2 Study (NEPTUNE)
Robert C. Wang, MD, FASRS
Annual Meeting Talks
2024
A Titanium Macular Buckle Implant Designed for an Easy Placement in Myopic Macular Holes
Levent Akduman, MD, FASRS
Annual Meeting Talks
2021